If the sponsor has temporarily halted a clinical investigation or has terminated a clinical investigation early, it shall inform within 15 days the Member State in which that clinical investigation has been temporarily halted or terminated early, through the electronic system referred to in Article 73, of the temporary halt or early termination, providing a justification.
Má stad an t-urraitheoir imscrúdú cliniciúil go sealadach nó má chuir sé deireadh luath leis, cuirfidh sé in iúl don Bhallstát inar cuireadh stad sealadach nó deireadh luath leis an imscrúdú cliniciúil sin, laistigh de 15 lá, tríd an gcóras leictreonach dá dtagraítear in Airteagal 73, gur cuireadh stad sealadach nó deireadh luath leis an imscrúdú, agus míneoidh sé na cúiseanna a bhí leis.